Results of Scrip Dividend Alternative Election
6 April 2020
ALPHA REAL TRUST LIMITED ("ALPHA REAL TRUST" OR THE "COMPANY")
RESULTS OF SCRIP DIVIDEND ALTERNATIVE ELECTION
Scrip dividend alternative elections were received in respect of 29,972,146 shares representing a take up of 49% of the Company's share capital as at the record date for the dividend. This will result in the issue of 186,628 new ordinary shares (approximately 0.3% of the current issued share capital). These shares will be issued at a price of 160.6 pence each and will rank pari passu in all respects with the Company's existing issued ordinary shares.
An application has been made to the London Stock Exchange for these shares to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange's Main Market. It is expected that admission will occur on 9 April 2020.
Following the issue of these shares, the ordinary share capital of the Company will be 61,840,870 (including 1,940,797 Ordinary Shares held in treasury) and the total voting rights in the Company will be 59,900,073 with effect from 9 April 2020. The figure of 59,900,073 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, ART under the FCA's Disclosure and Transparency Rules.
Share certificates will be posted to certificated shareholders who elected for scrip dividend shares and shareholders holding shares in CREST, who elected for scrip dividend shares, will have their CREST accounts credited directly on 9 April 2020.
For further information please contact:
Alpha Real Trust Limited
David Jeffreys, Chairman, Alpha Real Trust +44 (0) 1481 742 742
Brad Bauman, Joint Fund Manager, Alpha Real Trust +44 (0) 20 7391 4700
Panmure Gordon, Broker to the Company
Atholl Tweedie +44 (0) 20 7886 2500
Further information on the Company can be found on the Company's website: www.alpharealtrustlimited.com.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.